Yahoo
HKSE - Delayed Quote HKD

Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK)

11.130 +0.080 (+0.72%)
As of 11:59:25 AM GMT+8. Market Open.
Chart Range Bar
Loading chart for 2607.HK
  • Previous Close 11.050
  • Open 11.120
  • Bid 11.130 x --
  • Ask 11.140 x --
  • Day's Range 11.060 - 11.150
  • 52 Week Range 10.700 - 12.390
  • Volume 625,300
  • Avg. Volume 1,679,308
  • Market Cap (intraday) 41.274B
  • Beta (5Y Monthly) 0.13
  • PE Ratio (TTM) 7.09
  • EPS (TTM) 1.570
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 0.52 (4.72%)
  • Ex-Dividend Date Sep 16, 2026
  • 1y Target Est 13.86

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

www.sphchina.com

49,608

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

2607.HK
2.61%
SSE Composite Index (000001.SS)
8.99%

1-Year Return

2607.HK
0.35%
SSE Composite Index (000001.SS)
9.16%

3-Year Return

2607.HK
10.71%
SSE Composite Index (000001.SS)
19.18%

5-Year Return

2607.HK
0.63%
SSE Composite Index (000001.SS)
3.25%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 75.49B
Earnings 1.08B
Profit Margin 1.43%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
20B
40B
60B
1.0%
1.5%
2.0%
2.5%

Analyst Insights

View More

Analyst Price Targets

9.97 Low
13.86 Average
11.130 Current
16.70 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.77%

  • Return on Assets (ttm)

    2.36%

  • Return on Equity (ttm)

    7.36%

  • Revenue (ttm)

    291.47B

  • Net Income Avi to Common (ttm)

    5.16B

  • Diluted EPS (ttm)

    1.570

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    42.25B

  • Total Debt/Equity (mrq)

    61.22%

  • Levered Free Cash Flow (ttm)

    397.98M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: